Evaluating UnitedHealth Group In opposition to Friends In Well being Care Suppliers & Companies Trade – UnitedHealth Group (NYSE:UNH)

0
4
Evaluating UnitedHealth Group In opposition to Friends In Well being Care Suppliers & Companies Trade – UnitedHealth Group (NYSE:UNH)


In at present’s quickly altering and extremely aggressive enterprise world, it’s critical for traders and trade lovers to fastidiously assess corporations. On this article, we’ll carry out a complete trade comparability, evaluating UnitedHealth Group UNH towards its key opponents within the Well being Care Suppliers & Companies trade. By analyzing vital monetary metrics, market place, and development prospects, we goal to supply useful insights for traders and make clear firm’s efficiency inside the trade.

UnitedHealth Group Background

UnitedHealth Group is without doubt one of the largest personal well being insurers, offering medical advantages to about 50 million members globally, together with 1 million outdoors the us as June 2024. As a frontrunner in employer-sponsored, self-directed, and government-backed insurance policy, UnitedHealth has obtained huge scale in managed care. Together with its insurance coverage property, UnitedHealth’s continued investments in its Optum franchises have created a healthcare companies colossus that spans every little thing from medical and pharmaceutical advantages to offering outpatient care and analytics to each affiliated and third-party clients.

Firm P/E P/B P/S ROE EBITDA (in billions) Gross Revenue (in billions) Income Progress
UnitedHealth Group Inc 34.10 5.11 1.25 6.59% $9.73 $21.39 8.55%
Molina Healthcare Inc 15.21 3.59 0.44 6.78% $0.51 $1.19 20.96%
Progyny Inc 30.42 3.57 1.56 2.34% $0.01 $0.06 2.04%
Common 22.82 3.58 1.0 4.56% $0.26 $0.62 11.5%

By conducting an in-depth evaluation of UnitedHealth Group, we will determine the next tendencies:

  • The Worth to Earnings ratio of 34.1 for this firm is 1.49x above the trade common, indicating a premium valuation related to the inventory.

  • The elevated Worth to Ebook ratio of 5.11 relative to the trade common by 1.43x suggests firm could be overvalued primarily based on its guide worth.

  • With a comparatively excessive Worth to Gross sales ratio of 1.25, which is 1.25x the trade common, the inventory could be thought-about overvalued primarily based on gross sales efficiency.

  • The corporate has a better Return on Fairness (ROE) of 6.59%, which is 2.03% above the trade common. This means environment friendly use of fairness to generate earnings and demonstrates profitability and development potential.

  • The corporate reveals greater Earnings Earlier than Curiosity, Taxes, Depreciation, and Amortization (EBITDA) of $9.73 Billion, which is 37.42x above the trade common, implying stronger profitability and strong money stream technology.

  • With greater gross revenue of $21.39 Billion, which signifies 34.5x above the trade common, the corporate demonstrates stronger profitability and better earnings from its core operations.

  • The corporate is witnessing a considerable decline in income development, with a price of 8.55% in comparison with the trade common of 11.5%, which signifies a difficult gross sales atmosphere.

Debt To Fairness Ratio

The debt-to-equity (D/E) ratio offers insights into the proportion of debt an organization has in relation to its fairness and asset worth.

Contemplating the debt-to-equity ratio in trade comparisons permits for a concise analysis of an organization’s monetary well being and threat profile, aiding in knowledgeable decision-making.

In gentle of the Debt-to-Fairness ratio, a comparability between UnitedHealth Group and its prime 4 friends reveals the next info:

  • Amongst its prime 4 friends, UnitedHealth Group has a better debt-to-equity ratio of 0.83.

  • This means a better reliance on debt financing, which might expose the corporate to elevated monetary threat and potential volatility.

Key Takeaways

For UnitedHealth Group, the PE, PB, and PS ratios are all excessive in comparison with its friends within the Well being Care Suppliers & Companies trade, indicating probably overvalued inventory. However, the excessive ROE, EBITDA, and gross revenue recommend robust profitability and operational effectivity. Nevertheless, the low income development price could elevate considerations concerning the firm’s future efficiency relative to its trade opponents.

This text was generated by Benzinga’s automated content material engine and reviewed by an editor.

Overview Score:

Speculative

Market Information and Information dropped at you by Benzinga APIs



Supply hyperlink

LEAVE A REPLY

Please enter your comment!
Please enter your name here